Tianjin Chase Sun Pharmaceutical Co.,Ltd (300026.SZ) SHZ

3.25

-0.04(-1.22%)

Updated at June 02 03:04PM

Currency In CNY

Valuation

Market Cap10.57B
Enterprise Value9.61B
P/E Ratio447.18
PEG Ratio-0.14
Price/Sales Ratio2.09
Price/Book Ratio1.24
Enterprise/Revenue1.83
Enterprise/EBITDA23.33

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.01
Operating Margin0.03

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue4.9B
Revenue/Share1.42
Gross Profit2.65B
EBITDA523.21M
Net Income18.5M
Diluted EPS0.01

Balance Sheet

Total Cash1.56B
Total Cash/Share0.47
Total Debt351.59M
Total Debt/Equity0.04
Current Ratio4.7
Book Value Per Share2.65

Price History

52-Week Change-19.75
52-Week High4.49
52-Week Low3.16
Moving Average 50 Days3.43
Moving Average 200 Days3.64

Statistics

Average Volume36.8M
Shares Outstanding3B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.03
Trailing Annual Dividend Yield0.92
Payout Ratio7.75
Last Split Factor3:1
Last Split DateOctober 26, 2016